Juvenile myelomonocytic leukemia (JMML) · line 1 · Allogeneic hematopoietic cell transplant pathway for JMML
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | transplant |
| Linked regimen | REG-ALLOHCT-JMML |
| ID | IND-JMML-1L-ALLOHCT |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-11 |
| Diseases | DIS-JMML |
| Sources | SRC-COG |
Notes
Coverage-enabling stub for DIS-JMML. Requires pediatric hematology and transplant co-lead signoff before clinical publication.
Used By
Algorithms
ALGO-JMML-1L- ALGO-JMML-1L